COVID-19: Pfizer-BioNTech vaccine now 95% effective and will be submitted for authorisation 'within days'

The Pfizer-BioNTech vaccine has now proved 95% effective in preventing coronavirus and has met the safety criteria needed for emergency authorisation, the firms have said.